The most common mechanism is EGFR T790M mutation in exon 20 which accounts for approximately 50% of all EGFR TKIs resistance in NSCLC patients, more than half of which arises from T790M mutation in exon 20 (12, 13). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.